Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Efficacy and Safety of the Fixed-dose Combination of Coumarin and Troxerutin (Venalot®) Versus Placebo in the Symptomatic Treatment of Chronic Venous Insufficiency - VENACT

NCT01848210 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01848210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01848210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Efficacy and Safety of the Fixed-dose Combination of Coumarin and Troxerutin (Venalot®) Versus Placebo in the Symptomatic Treatment of Chronic Venous Insufficiency - VENACT
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2013
Completion date
September 30, 2015
Enrollment
829 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic venous insufficiency